News

ResMed slightly beats quarterly profit estimates, shrugs tariff concerns
Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder. The company manufactures continuous ...
Zacks Investment Research on MSN1h
ResMed (RMD) Q3 Earnings and Revenues Surpass Estimates
ResMed (RMD) came out with quarterly earnings of $2.37 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $2.13 per share a year ago. These figures are ...
ResMed’s (NYSE:RMD) Q1 Earnings Results: Revenue In Line With Expectations
Medical device company ResMed (NYSE:RMD) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.9% year on year ...
ResMed: Fiscal Q3 Earnings Snapshot
SAN DIEGO (AP) — SAN DIEGO (AP) — ResMed Inc. (RMD) on Wednesday reported fiscal third-quarter profit of $365 million. On a per-share basis, the San Diego-based company said it had profit of $2.48.
ResMed slightly beats quarterly profit estimates on sleep devices demand
Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.